{"ticker": {"uuid": "f22c9666-cdb5-4ff3-9539-3ca4f4fe7e65", "symbol": "SGRY", "name": "Surgery Partners Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Care Facilities"}, "articles": [{"title": "Form 4 Surgery Partners Inc For: 14 July By Investing.com", "summary": "This article from Investing.com is a regulatory filing update, announcing the Form 4 filing for Surgery Partners Inc. for July 14th. It primarily serves as a notification of insider transactions, as reported by Reuters. The article is very brief and contains no additional details", "url": "https://ng.investing.com/news/stock-market-news/form-4-surgery-partners-inc-for-14-july-93CH-2599623", "source_name": "Investing.com Nigeria", "published_at": "2026-07-15T11:12:44", "published_display": "15 Jul 2026 11:12", "sentiment": "positive", "sentiment_pct": 59, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) director receives 34,364 restricted stock awards", "summary": "Blair E. Hendrix, a director at Surgery Partners, Inc. (SGRY), was granted 34,364 restricted stock awards (RSAs) on June 18, 2026, at a price of $14.55 per share. These RSAs will vest in three equal annual installments starting one year after the grant date. Following this award,", "url": "https://www.stocktitan.net/sec-filings/SGRY/form-4-surgery-partners-inc-insider-trading-activity-93f34ac4b1a2.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:39:48", "published_display": "14 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Surgery Partners (SGRY) Reframing Its Profit Engine With Higher-Acuity Outpatient Surgeries?", "summary": "Surgery Partners (SGRY) is shifting its focus to higher-acuity outpatient surgeries by investing in robotics and facility upgrades. This strategy aims to enhance revenue per case, though investors should consider the impact of elevated debt costs. The company recently authorized ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-sgry/surgery-partners/news/is-surgery-partners-sgry-reframing-its-profit-engine-with-hi", "source_name": "Simply Wall Street", "published_at": "2026-07-13T21:35:16", "published_display": "13 Jul 2026 21:35", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) Could Be 9% Undervalued As Outpatient Surgery Growth Narrative Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNMl8wUFMtSndlal9oXzdOcVRSajNEZ2lMQWNNeTN5Sno1T29scFJRenN4Vmt1dVdNNXNJd1Y1dEJONnhTc1JUaFZiWFVKa1NVcWVab29EWUlvdDRicFhKLXVVZ2RpNEVZdjh5d0g3OEtldUJDUW5JZkNvT21JOERnVDF4NU1zVjhIUjczUnd1RWd5WWNxRGJwZjRn?oc=5", "source_name": "Market source", "published_at": "2026-07-11T17:06:24+00:00", "published_display": "11 Jul 2026 17:06", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fast-paced Momentum Stock Surgery Partners (SGRY) Is Still Trading at a Bargain", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOWHVacFpYZWJVdXIxaUc0Y3ZZUjhmX1lmMWY2ZW9xaWdtVkotYU5fX2RpakZRMkxZTE9NU19BY09rNXpkN2lFMW5PMGQtSWsxV1M5VXJvdW5mQm9EY1MxVE1WZkoxdUZNaWxOT2tsTDYzTlY5UW4xWXVjVi0zc3BESHJmQTNJSWEyX21CN3lrTGVNTEl2ZVJwS05QU2ZOVDA?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners focuses on specialty care as investors watch US healthcare trends", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPX3hFS0xLeC1FSTJmTGlHMWlfMkNOZGpNd3JMd3BZamFwQmpXalYwRW9aN0RPbGdoWHhvY1ZqZ2NCTlRJdFJ1UEgycnppV2oyWm05MFFsTkp4QmtzUXlfd2I3c2FPRmtqenFRRVIyLTkyQk1JTTBqT1FUQmtNWjBuaUFpbVhONVlJSDNxLU9GQy1ZVy05Ui1TQUwtMm5YWWJ6V2pwUVdpY1c3UTE3VXo0VDVhNGxBQ19BVG9WbkJSR0Y?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-07T17:06:27+00:00", "published_display": "07 Jul 2026 17:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners | 4: Statement of changes in beneficial ownership of securities-Officer Doherty David T", "summary": "This document is a Statement of Changes in Beneficial Ownership of Securities (Form 4) filed by David T. Doherty, an officer of Surgery Partners. It details changes in his ownership of the company's securities.", "url": "https://www.moomoo.com/news/notice/306669421/surgery-partners-4-statement-of-changes-in-beneficial-ownership-of", "source_name": "Moomoo", "published_at": "2026-07-06T22:12:26", "published_display": "06 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Surgery Partners, Inc. \u2013 DUS:1SP", "summary": "This page provides financial information for Surgery Partners, Inc. (1SP) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to forward EBITDA. The content is part of a larger financial data platform, TradingView, which offers various tools and resour", "url": "https://www.tradingview.com/symbols/DUS-1SP/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T08:10:57", "published_display": "06 Jul 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "This article provides the enterprise value to EBITDA forward for Surgery Partners, Inc. (NASDAQ: SGRY). It is a brief financial snippet from TradingView, indicating that the data is presented without further elaboration.", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T00:00:35", "published_display": "06 Jul 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "The article discusses the enterprise value to EBIT forward for Surgery Partners, Inc. (NASDAQ: SGRY). It appears to be a financial data snippet from TradingView, indicating a specific financial metric for the company. The content itself is very brief and seems to be a placeholder", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T14:39:15", "published_display": "05 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Surgery Partners, Inc. \u2013 DUS:1SP", "summary": "This article provides financial information for Surgery Partners, Inc. (DUS:1SP) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to EBIT forward. It indicates that the market is currently closed with no trades. The content is presented without furt", "url": "https://www.tradingview.com/symbols/DUS-1SP/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T13:40:36", "published_display": "05 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "This article provides financial data for Surgery Partners, Inc. (NASDAQ: SGRY), specifically focusing on its forward price-to-earnings ratio. It lists various sections related to the company's financials, news, and technical analysis available on the TradingView platform. The con", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T08:10:57", "published_display": "05 Jul 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) Drew Fresh Optimism, Is It Still Only 4% Undervalued?", "summary": "Surgery Partners (SGRY) saw its stock rise by 2.7% after positive commentary from Cantor Fitzgerald, which projected profitability and net income growth despite recent soft operating trends. Although the stock has seen significant short-term gains, its one-year return is still do", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-sgry/surgery-partners/news/surgery-partners-sgry-drew-fresh-optimism-is-it-still-only-4", "source_name": "Simply Wall Street", "published_at": "2026-07-03T20:12:26", "published_display": "03 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGRY - Surgery Partners Inc Latest SEC Filings", "summary": "This article provides a detailed financial overview of Surgery Partners Inc (SGRY), including its latest stock performance, key financial metrics, valuation ratios, and ownership details. It highlights the company's recent stock close, percentage change, and various profitability", "url": "https://finviz.com/stock?t=SGRY&b=2&p=d&ty=lf&page=8", "source_name": "Finviz", "published_at": "2026-07-03T19:09:39", "published_display": "03 Jul 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Surgery Partners (SGRY) Stock Is Trading Up Today", "summary": "Shares of healthcare company Surgery Partners (SGRY) rose by 2.7% following Cantor Fitzgerald's reiteration of an \"Overweight\" rating and an $18.00 price target. Despite some negative trends in Q2 data acknowledged by the analyst, the overall outlook for the company remains posit", "url": "https://www.tradingview.com/news/stockstory:b0b50375d094b:0-why-surgery-partners-sgry-stock-is-trading-up-today/", "source_name": "TradingView", "published_at": "2026-07-02T15:14:19", "published_display": "02 Jul 2026 15:14", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners stock rating maintained at Overweight by Cantor", "summary": "Cantor Fitzgerald has reiterated its Overweight rating for Surgery Partners (NASDAQ:SGRY) and maintained an $18.00 price target. Despite slight negative trends in Q2 2026 for ambulatory surgery centers and outpatient nursing, the firm noted these were not significant enough to in", "url": "https://www.investing.com/news/analyst-ratings/surgery-partners-stock-rating-maintained-at-overweight-by-cantor-93CH-4773115", "source_name": "Investing.com", "published_at": "2026-07-02T12:14:19", "published_display": "02 Jul 2026 12:14", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight", "summary": "Cantor Fitzgerald has reiterated its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a price target of $18.00, despite the stock being slightly overvalued according to InvestingPro data. The firm's analysis indicates less optimistic views on outpatient pricing step-up th", "url": "https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-reiterates-surgery-partners-stock-rating-at-overweight-93CH-4770254", "source_name": "Investing.com", "published_at": "2026-07-01T11:41:57", "published_display": "01 Jul 2026 11:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Surgery Partners, Inc. \u2013 FWB:1SP", "summary": "This article provides the enterprise value to revenue forward for Surgery Partners, Inc. (FWB:1SP). It lists basic financial information available on TradingView for the company. The content appears to be a stub or a data point from a larger financial platform.", "url": "https://www.tradingview.com/symbols/FWB-1SP/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T12:11:25", "published_display": "30 Jun 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "The TradingView platform provides financial data for Surgery Partners, Inc. (NASDAQ: SGRY), specifically focusing on its price to book forward metric. The platform offers an overview, financials, news, and other data for the company, indicating that the market for SGRY is current", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T12:11:25", "published_display": "30 Jun 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "This article provides the \"Price to sales forward\" metric for Surgery Partners, Inc. (NASDAQ: SGRY). It is presented as a financial data point without additional analysis or context within the provided content. The data is made available by FactSet Research Systems Inc.", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T05:03:22", "published_display": "30 Jun 2026 05:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Surgery Partners, Inc. \u2013 FWB:1SP", "summary": "This page provides financial information for Surgery Partners, Inc. (FWB:1SP) on TradingView, specifically focusing on its forward price-to-earnings ratio. It is a financial data page rather than an analytical article, showing data across various periods.", "url": "https://www.tradingview.com/symbols/FWB-1SP/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T04:10:22", "published_display": "30 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners, Inc. (SGRY) Investigation: Bronstein, Gewirtz", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Surgery Partners, Inc. (NASDAQ:SGRY) securities. This investigation follows a significant drop in Surgery Partners' stock price after the company lowered its full-year revenue and adju", "url": "https://natlawreview.com/press-releases/surgery-partners-inc-sgry-investigation-bronstein-gewirtz-grossman-llc-2", "source_name": "The National Law Review", "published_at": "2026-06-29T22:10:16", "published_display": "29 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 29, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners, Inc. Actuals & Estimates (NASDAQ:SGRY)", "summary": "This article provides current financial data and analyst estimates for Surgery Partners, Inc. (NASDAQ:SGRY), including its stock price, market capitalization, earnings, and revenue. It details historical performance, future forecasts, and answers frequently asked questions about ", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T05:39:57", "published_display": "27 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGRY Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a detailed forecast and price target for Surgery Partners, Inc. (SGRY) for 2027, based on analyst opinions. It includes financial data such as current stock price, market capitalization, revenue, and earnings, along with historical performance and volatility", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T17:10:55", "published_display": "26 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A14YWP Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Surgery Partners, Inc. (A14YWP) stock, based on analyst opinions. It includes financial data such as current stock price, market capitalization, earnings, revenue, and dividend information, while also addressing frequently ask", "url": "https://www.tradingview.com/symbols/LS-A14YWP/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T15:39:57", "published_display": "26 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners, Inc. Actuals & Estimates (MUN:1SP)", "summary": "This article provides financial actuals and estimates for Surgery Partners, Inc. (MUN:1SP), including income statement, balance sheet, and cash flow data, alongside analyst forecasts. It details the company's next earnings report date, past earnings and revenue performance, EBITD", "url": "https://www.tradingview.com/symbols/MUN-1SP/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T20:10:02", "published_display": "25 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tranche Update on Surgery Partners, Inc.'s Equity Buyback Plan announced on March 2, 2026.", "summary": "Surgery Partners, Inc. reported an update on its equity buyback plan, originally announced on March 2, 2026. Between February 26, 2026, and March 31, 2026, the company did not repurchase any shares or allocate any funds towards the buyback plan. This indicates no activity in the ", "url": "https://www.marketscreener.com/news/tranche-update-on-surgery-partners-inc-s-equity-buyback-plan-announced-on-march-2-2026-ce7f5cd3dd80f522", "source_name": "www.marketscreener.com", "published_at": "2026-06-22T12:40:43", "published_display": "22 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Fast-paced Mover Surgery Partners (SGRY) Is a Great Choice for Value Investors", "summary": "Surgery Partners (SGRY) is identified as an attractive investment for value investors due to its fast-paced momentum and reasonable valuation. The stock has shown significant price increases over recent weeks and boasts a high beta, indicating strong market movement. Additionally", "url": "https://finance.yahoo.com/markets/stocks/articles/why-fast-paced-mover-surgery-125502095.html", "source_name": "Market source", "published_at": "2026-06-22T06:55:00", "published_display": "22 Jun 2026 06:55", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks", "summary": "This article analyzes Q1 earnings for outpatient and specialty care stocks, highlighting Surgery Partners (NASDAQ:SGRY) performance. It also compares SGRY with top performer agilon health (NYSE:AGL) and weaker performer U.S. Physical Therapy (NYSE:USPH), along with Select Medical", "url": "https://www.theglobeandmail.com/investing/markets/stocks/SGRY-Q/pressreleases/2553171/unpacking-q1-earnings-surgery-partners-nasdaqsgry-in-the-context-of-other-outpatient-specialty-care-stocks/", "source_name": "The Globe and Mail", "published_at": "2026-06-20T01:40:43", "published_display": "20 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners Stock - weekly sector check after quiet news flow", "summary": "Surgery Partners (SGRY) stock has shown modest gains recently with quiet news flow. This article provides a weekly sector check, comparing SGRY's performance against healthcare peers and the broader market, and offers an overview of the company's operations and key financial fact", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/surgery-partners-stock-weekly-sector-check-after-quiet-news-flow/69584674", "source_name": "AD HOC NEWS", "published_at": "2026-06-19T17:39:41", "published_display": "19 Jun 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGRY - Outpatient Shifts And CMS Changes Will Expand Surgical Potential", "summary": "Surgery Partners (SGRY) is positioned for growth due to outpatient surgical shifts and favorable CMS changes, yet faces near-term challenges. Recent analyst re-evaluations, following Q4 results and updated 2026 guidance, show a mixed outlook regarding margins, payer mix, and M&A ", "url": "https://simplywall.st/narratives/3ichyd7r-outpatient-shifts-and-cms-changes-will-expand-surgical-potential-v7so?bpId=4630650&link_type=cta_narrative_prompt_after_quote", "source_name": "Simply Wall Street", "published_at": "2026-06-19T15:39:40", "published_display": "19 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-analysts-see-26-135503736.html", "source_name": "Zacks", "published_at": "2026-06-18T13:55:03+00:00", "published_display": "18 Jun 2026 13:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNdHN4Z2Q0Njh1c1pxNzVLRnczcHV2cHNLZWI1QnVNbTBTVU5XNHhjcXdEeG9UNnBObGRrcGNFbjdqdG16SE5qY016a3hKbElqdVZKNHREMzZ2TkJLcGFtcjBjRndKTmhTV0p0OXVaZks2cFBubjlDOGtVVXpyS0pkY0RsUUV2SWNZWFUzNzRQOGRkRm5KTlFRRk05aGIwM3VIVXdUb3FpcGVJTWlDamJlLXl3WnFpY09tVi13ZU9OOU04bE1QZ2pCbkM0c29HZkRyenpjRmhXSXdMZw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Revealing Analyst Questions From Surgery Partners\u2019s Q1 Earnings Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPQTNEUjJteWFoUzl2WEJPbE1RdnBUTno5QndjNGdSdEFGTFd0OXNFYmNFTUtXNy0xRmota3BGeVhmbFpRTG9BdTZwNWRMeDJETWxqT0lycUE1QjM5azVjOVQ1aC1xdVRmbEZvakxCMV93eUlpanFtSGJJeWxKMTJpWlR5VVhTQVpETmhNYVpJNXQ0bS1sRk9IejlMdWhHVmZuRDdHWE9Wa20yVEU4TFoxMHdvVW0yU0l5R29Nak5mQ0JwNmlyRmc3TEVRTXVmdw?oc=5", "source_name": "StockStory", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) Losses Of US$77.9 Million Keep Profitability Narrative Under Pressure", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Surgery Partners Q1 2026 earnings beat forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxObEFQbkJNTFNCdWVkcmZDZTZSNmZGcTZEMlJKUTdBTW9tMFM3TjJhaGN3cDRSNmMxcmJ3T3Utb0Q5MUlJTkMtNFZVNUhZbG9YRlYxczd4clZMXzZlbG9oeVFpa0M5WlBxYzFMZmJLY3c5RVBFSklrWnpodTcwYklDcnNIcS1aSUxzS2VRQXV6bkNaMV9lVl9NRnhaaEFKSEdaNUlDZWdwRldmUVpJdVpxa3FoNzJEcDNoVkZHY2dRRUZtSWJZeHZQag?oc=5", "source_name": "Investing.com", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners\u2019s (NASDAQ:SGRY) Q1 CY2026 Sales Beat Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQZ1VBajBVMzJUZFgtUmpkaFJMU1dlWGlTYW80ZGxORGRRX0hRNzlBeDFELWllY2pJUjBLSm9IUWpfSFpPVkJwaTdYT1hDQXF6ODQ4cmxqS0ZQRDhacFhsOUhiRTJpbFVQcUdMbUw3cTJ3WDJvUTMtZVQtUzd0d0ZVU3Z4SHp1Zy1KcEMxV1FaQU9sWFNUOW1ETmh2ZmJmcWVFaEpQQjY5cDU4R09zRjhyMENNa1JPR2ZMc0E?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOdzRxakh6ZW1DeTZ2aEY3SjZYLTgzMmpxY1AtTW9mOFM2c1BjZkNhNFNRbzlRYW9GTERPWmpPQ1o1NEZ6YlB4aFFkb1UtWUVpRndHT1lRVzdzbjNHZXU1UmpjSGtmczh0MEtOZWI5Q1dNM2dPMk04ZDR3YTZtQW1FQmZjYloyanktNnY5VmlUTlBtQXFkYkxwYnNIU1QxV1NOYU9z?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners Inc. (SGRY): Billionaire Brian Higgins Likes This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQWHgwM1VFTlBNUHEyZ3Z4ZW9aZnJiVHFhYjdZWllGVU95OVBtbzBtbENBTHNxUGJ5ODNrODBDZzU0NFEyTDRCbko2bUd5OUNrRHNYVnNzNkR4VkFrc2xWQnN5YlM3UzB3d3M2YlVubEgxc1FoU05OZWlCZGZLTFZhNXJlT2E0eVZwODJSbUx4cGk1eXlsSnJoaGVJU0ZGODBxNjVBNA?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners posts Q1 results May 5, webcast at 8:30 ET", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOT1d3Z2VHZWQ5a0dkNm56SXBVTlNhZzZSTFNzLTZvMlU4VTJwb0xFS2I5czZTZldGRWFlQWpyV3AxeFJuWnRxR2xRbTRFcTNpZ3lhcTc2U045MGNqM2V0ZHZNaDctZUJwR3B2ZFVHNWQ0YVBlbXpMNFF6Y1JJZzBZX0dTSzE3WVVHOHJ1WThwRUk0bEVWbG1vaG1kSzZSTk9BNnBYRUlhWmRSZk01OUZvMzBzLW9rYk95SXhpaHNR?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evans, Surgery Partners CEO, sells $254k in SGRY stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNcENTWTBwVS13YXByN2g5VU9idnR6N0RjYXlyQVJ6SzVmQktaRWN6Q2NnNVlRXzN5SFZBeTRLakpoT2FvbGJzaFZJc3lnZ0E3SnNteXE1NTBHNjgyc3g1cWlTNEdwSWlLMVNJZDFQYUt1OFA4M0lJRExhNXpMMlBjN00ySk9mUndyRTBab1lrTklQT0hVV2NON1N1WURueThQZUxHMmFLazFVTW9xOHpRUmZVQTRoUEU?oc=5", "source_name": "Investing.com", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hear Surgery Partners\u2019 Barclays healthcare presentation live online", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOODlMcU1OZUh1bFdGUEVQSHhtclRBNVZmWHB1OXNJSVlIZ3h3VDJ2S1V4YWpsV19jazhpcHZxa2pWU3ZFQzFKV29QYzJ4bGJiM0ZpZ1ZBSUM4anBLR05WTm0tWi1vT1JsQVF6bFNvR2pJQjJoSk5QcnQtNGNmWGNXNW1tZ0t4bjF3UXhBME9OQ0t3NlUtRlZxMmtnQlBLaENkeDhhMXh4c1NJN28?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Outpatient & Specialty Care Stocks Q4 Highlights: Surgery Partners (NASDAQ:SGRY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNanVnVjNMRHM3LUE1WXd1Unh3WUpPQnpsUTRkeXA3cFU1WV9xX3BvMV84aE9aWnFhYnJndlN4RjN0dlplNV9Md3VobHJyZS0xXzBxODc4UGhBVndndmRfbEdFbWpLVkpkVng3NVZsY2VvaFczdDV5OFVscmdpcnRtUDRqeXRSWWVXd2FNZXRUa2ZmMTlGcVJELWhSd1VYXy1LVHJLSU1QVjRpZw?oc=5", "source_name": "Finviz", "published_at": "2026-03-08T08:00:00+00:00", "published_display": "08 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners Inc. (SGRY) Stock Falls on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOWnk4WUdjM1pFaTF1b21VMHMzZUwtUzhFWVYwNmhtNXUwYUhTU0REU00wQnNVUjN4TlBveERWMDhXc3ZPM1VxbTBmWDBlX1F6a2E3RzJSWjdiVmdYSkJ0N1dOYUh0ZkJVOUFwQ2d2eVctN2kxdnFXcXBrZ2FNY0JLNTdFMndoT084NFlHdXRvT3hpQktSTkp1LU56SW9zQQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners schedules March 3 call to explain Q4 2025 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOdEN6MXVtY0dUc1BKR08zcm9sU25NWVF1bkUtUjRLSUN2b3huWjdfc0gxYWdLelRNV2gtcnhGaGt2UU1LN2lTRm5YWG50XzBaOGVIVXE0ZU5UX3BObEpabmxfWHYtUU81SGl2RnRZdnRGeG5qbk9IbTRwR01sR2VFcnRJaUtDanB6eF84NlR2R082Ym01YmhJajAyeFE3SjFxbTVyeHBfaDlPTnljbFI4eGtGX2ZINGJkaGVSeFNuVQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNUktKT2wzSEZMelh1cjhlWmJyZFNRSWtBZXhsMzVkc2ZKVW0zR2J0T0FpWC1YOXZ1SjRucnJNLTQ4ZGRVN2E2WVdNenI5U3VWeUZxekw2V2Z0TXZZU1RDcjJjSTV5WjVLSHpXeU92cU1BRVpkWno4Q1Y5U0NyWkdneFN5ZWN4ZE5lcmJXaG5yaUZKZ1VnWmNlYXhPTm9UMXZMYW8tOHZFeEpHYlhVc1lhbnd1WUVrWG9pY3BndEtoUF8?oc=5", "source_name": "The Motley Fool", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Surgery Partners (SGRY) Is Down 26.1% After Lower Q3 Results and Reduced 2025 Revenue Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQN25zTW1GUkN6eTZEMXB4Tk5wN1BtRUxTSzhzMWRsdkl4aV96eHZNX0ZmVU04VHBtd0pYQzBlUzN4ZUdZRnpBTm1mUE1XMGdJSEp3aEhXeHdrUlJMcTdWYWpyNU1wbHd1X2UzYUhWa3BpcHBtcks0ckh5RW5CWjlyNkZ3?oc=5", "source_name": "Market source", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Surgery Partners (SGRY) Stock Is Trading Lower Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOT1VZRnVUZjZTZ21RM1YxdmxIN2xpZ2tfVDlHSVRUMjByUWNvSXdNckw2WjBCQ0hSZnZEWUZ1Y1ZWdUtzWVN5TEFGcDJERWpkQXhtUmpDaUhHNzVMY0VTek1pMnlYcnlkTlV5WVFhOUNnVFFGZUhiY0d3aGxpamNpLTFfRQ?oc=5", "source_name": "Market source", "published_at": "2025-11-10T08:00:00+00:00", "published_display": "10 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Form 4 Surgery Partners Inc For: 14 July By Investing.com", "summary": "This article from Investing.com is a regulatory filing update, announcing the Form 4 filing for Surgery Partners Inc. for July 14th. It primarily serves as a notification of insider transactions, as reported by Reuters. The article is very brief and contains no additional details", "url": "https://ng.investing.com/news/stock-market-news/form-4-surgery-partners-inc-for-14-july-93CH-2599623", "source_name": "Investing.com Nigeria", "published_at": "2026-07-15T11:12:44", "published_display": "15 Jul 2026 11:12", "sentiment": "positive", "sentiment_pct": 59, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) director receives 34,364 restricted stock awards", "summary": "Blair E. Hendrix, a director at Surgery Partners, Inc. (SGRY), was granted 34,364 restricted stock awards (RSAs) on June 18, 2026, at a price of $14.55 per share. These RSAs will vest in three equal annual installments starting one year after the grant date. Following this award,", "url": "https://www.stocktitan.net/sec-filings/SGRY/form-4-surgery-partners-inc-insider-trading-activity-93f34ac4b1a2.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:39:48", "published_display": "14 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Surgery Partners (SGRY) Reframing Its Profit Engine With Higher-Acuity Outpatient Surgeries?", "summary": "Surgery Partners (SGRY) is shifting its focus to higher-acuity outpatient surgeries by investing in robotics and facility upgrades. This strategy aims to enhance revenue per case, though investors should consider the impact of elevated debt costs. The company recently authorized ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-sgry/surgery-partners/news/is-surgery-partners-sgry-reframing-its-profit-engine-with-hi", "source_name": "Simply Wall Street", "published_at": "2026-07-13T21:35:16", "published_display": "13 Jul 2026 21:35", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) Could Be 9% Undervalued As Outpatient Surgery Growth Narrative Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNMl8wUFMtSndlal9oXzdOcVRSajNEZ2lMQWNNeTN5Sno1T29scFJRenN4Vmt1dVdNNXNJd1Y1dEJONnhTc1JUaFZiWFVKa1NVcWVab29EWUlvdDRicFhKLXVVZ2RpNEVZdjh5d0g3OEtldUJDUW5JZkNvT21JOERnVDF4NU1zVjhIUjczUnd1RWd5WWNxRGJwZjRn?oc=5", "source_name": "Market source", "published_at": "2026-07-11T17:06:24+00:00", "published_display": "11 Jul 2026 17:06", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fast-paced Momentum Stock Surgery Partners (SGRY) Is Still Trading at a Bargain", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOWHVacFpYZWJVdXIxaUc0Y3ZZUjhmX1lmMWY2ZW9xaWdtVkotYU5fX2RpakZRMkxZTE9NU19BY09rNXpkN2lFMW5PMGQtSWsxV1M5VXJvdW5mQm9EY1MxVE1WZkoxdUZNaWxOT2tsTDYzTlY5UW4xWXVjVi0zc3BESHJmQTNJSWEyX21CN3lrTGVNTEl2ZVJwS05QU2ZOVDA?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners focuses on specialty care as investors watch US healthcare trends", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPX3hFS0xLeC1FSTJmTGlHMWlfMkNOZGpNd3JMd3BZamFwQmpXalYwRW9aN0RPbGdoWHhvY1ZqZ2NCTlRJdFJ1UEgycnppV2oyWm05MFFsTkp4QmtzUXlfd2I3c2FPRmtqenFRRVIyLTkyQk1JTTBqT1FUQmtNWjBuaUFpbVhONVlJSDNxLU9GQy1ZVy05Ui1TQUwtMm5YWWJ6V2pwUVdpY1c3UTE3VXo0VDVhNGxBQ19BVG9WbkJSR0Y?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-07T17:06:27+00:00", "published_display": "07 Jul 2026 17:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners | 4: Statement of changes in beneficial ownership of securities-Officer Doherty David T", "summary": "This document is a Statement of Changes in Beneficial Ownership of Securities (Form 4) filed by David T. Doherty, an officer of Surgery Partners. It details changes in his ownership of the company's securities.", "url": "https://www.moomoo.com/news/notice/306669421/surgery-partners-4-statement-of-changes-in-beneficial-ownership-of", "source_name": "Moomoo", "published_at": "2026-07-06T22:12:26", "published_display": "06 Jul 2026 22:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Surgery Partners, Inc. \u2013 DUS:1SP", "summary": "This page provides financial information for Surgery Partners, Inc. (1SP) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to forward EBITDA. The content is part of a larger financial data platform, TradingView, which offers various tools and resour", "url": "https://www.tradingview.com/symbols/DUS-1SP/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T08:10:57", "published_display": "06 Jul 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "This article provides the enterprise value to EBITDA forward for Surgery Partners, Inc. (NASDAQ: SGRY). It is a brief financial snippet from TradingView, indicating that the data is presented without further elaboration.", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T00:00:35", "published_display": "06 Jul 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "The article discusses the enterprise value to EBIT forward for Surgery Partners, Inc. (NASDAQ: SGRY). It appears to be a financial data snippet from TradingView, indicating a specific financial metric for the company. The content itself is very brief and seems to be a placeholder", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T14:39:15", "published_display": "05 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Surgery Partners, Inc. \u2013 DUS:1SP", "summary": "This article provides financial information for Surgery Partners, Inc. (DUS:1SP) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to EBIT forward. It indicates that the market is currently closed with no trades. The content is presented without furt", "url": "https://www.tradingview.com/symbols/DUS-1SP/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T13:40:36", "published_display": "05 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "This article provides financial data for Surgery Partners, Inc. (NASDAQ: SGRY), specifically focusing on its forward price-to-earnings ratio. It lists various sections related to the company's financials, news, and technical analysis available on the TradingView platform. The con", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T08:10:57", "published_display": "05 Jul 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) Drew Fresh Optimism, Is It Still Only 4% Undervalued?", "summary": "Surgery Partners (SGRY) saw its stock rise by 2.7% after positive commentary from Cantor Fitzgerald, which projected profitability and net income growth despite recent soft operating trends. Although the stock has seen significant short-term gains, its one-year return is still do", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-sgry/surgery-partners/news/surgery-partners-sgry-drew-fresh-optimism-is-it-still-only-4", "source_name": "Simply Wall Street", "published_at": "2026-07-03T20:12:26", "published_display": "03 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGRY - Surgery Partners Inc Latest SEC Filings", "summary": "This article provides a detailed financial overview of Surgery Partners Inc (SGRY), including its latest stock performance, key financial metrics, valuation ratios, and ownership details. It highlights the company's recent stock close, percentage change, and various profitability", "url": "https://finviz.com/stock?t=SGRY&b=2&p=d&ty=lf&page=8", "source_name": "Finviz", "published_at": "2026-07-03T19:09:39", "published_display": "03 Jul 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Surgery Partners (SGRY) Stock Is Trading Up Today", "summary": "Shares of healthcare company Surgery Partners (SGRY) rose by 2.7% following Cantor Fitzgerald's reiteration of an \"Overweight\" rating and an $18.00 price target. Despite some negative trends in Q2 data acknowledged by the analyst, the overall outlook for the company remains posit", "url": "https://www.tradingview.com/news/stockstory:b0b50375d094b:0-why-surgery-partners-sgry-stock-is-trading-up-today/", "source_name": "TradingView", "published_at": "2026-07-02T15:14:19", "published_display": "02 Jul 2026 15:14", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners stock rating maintained at Overweight by Cantor", "summary": "Cantor Fitzgerald has reiterated its Overweight rating for Surgery Partners (NASDAQ:SGRY) and maintained an $18.00 price target. Despite slight negative trends in Q2 2026 for ambulatory surgery centers and outpatient nursing, the firm noted these were not significant enough to in", "url": "https://www.investing.com/news/analyst-ratings/surgery-partners-stock-rating-maintained-at-overweight-by-cantor-93CH-4773115", "source_name": "Investing.com", "published_at": "2026-07-02T12:14:19", "published_display": "02 Jul 2026 12:14", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight", "summary": "Cantor Fitzgerald has reiterated its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a price target of $18.00, despite the stock being slightly overvalued according to InvestingPro data. The firm's analysis indicates less optimistic views on outpatient pricing step-up th", "url": "https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-reiterates-surgery-partners-stock-rating-at-overweight-93CH-4770254", "source_name": "Investing.com", "published_at": "2026-07-01T11:41:57", "published_display": "01 Jul 2026 11:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Surgery Partners, Inc. \u2013 FWB:1SP", "summary": "This article provides the enterprise value to revenue forward for Surgery Partners, Inc. (FWB:1SP). It lists basic financial information available on TradingView for the company. The content appears to be a stub or a data point from a larger financial platform.", "url": "https://www.tradingview.com/symbols/FWB-1SP/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T12:11:25", "published_display": "30 Jun 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "The TradingView platform provides financial data for Surgery Partners, Inc. (NASDAQ: SGRY), specifically focusing on its price to book forward metric. The platform offers an overview, financials, news, and other data for the company, indicating that the market for SGRY is current", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T12:11:25", "published_display": "30 Jun 2026 12:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Surgery Partners, Inc. \u2013 NASDAQ:SGRY", "summary": "This article provides the \"Price to sales forward\" metric for Surgery Partners, Inc. (NASDAQ: SGRY). It is presented as a financial data point without additional analysis or context within the provided content. The data is made available by FactSet Research Systems Inc.", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T05:03:22", "published_display": "30 Jun 2026 05:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Surgery Partners, Inc. \u2013 FWB:1SP", "summary": "This page provides financial information for Surgery Partners, Inc. (FWB:1SP) on TradingView, specifically focusing on its forward price-to-earnings ratio. It is a financial data page rather than an analytical article, showing data across various periods.", "url": "https://www.tradingview.com/symbols/FWB-1SP/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T04:10:22", "published_display": "30 Jun 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners, Inc. (SGRY) Investigation: Bronstein, Gewirtz", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Surgery Partners, Inc. (NASDAQ:SGRY) securities. This investigation follows a significant drop in Surgery Partners' stock price after the company lowered its full-year revenue and adju", "url": "https://natlawreview.com/press-releases/surgery-partners-inc-sgry-investigation-bronstein-gewirtz-grossman-llc-2", "source_name": "The National Law Review", "published_at": "2026-06-29T22:10:16", "published_display": "29 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 29, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners, Inc. Actuals & Estimates (NASDAQ:SGRY)", "summary": "This article provides current financial data and analyst estimates for Surgery Partners, Inc. (NASDAQ:SGRY), including its stock price, market capitalization, earnings, and revenue. It details historical performance, future forecasts, and answers frequently asked questions about ", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T05:39:57", "published_display": "27 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGRY Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a detailed forecast and price target for Surgery Partners, Inc. (SGRY) for 2027, based on analyst opinions. It includes financial data such as current stock price, market capitalization, revenue, and earnings, along with historical performance and volatility", "url": "https://www.tradingview.com/symbols/NASDAQ-SGRY/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T17:10:55", "published_display": "26 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A14YWP Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Surgery Partners, Inc. (A14YWP) stock, based on analyst opinions. It includes financial data such as current stock price, market capitalization, earnings, revenue, and dividend information, while also addressing frequently ask", "url": "https://www.tradingview.com/symbols/LS-A14YWP/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T15:39:57", "published_display": "26 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners, Inc. Actuals & Estimates (MUN:1SP)", "summary": "This article provides financial actuals and estimates for Surgery Partners, Inc. (MUN:1SP), including income statement, balance sheet, and cash flow data, alongside analyst forecasts. It details the company's next earnings report date, past earnings and revenue performance, EBITD", "url": "https://www.tradingview.com/symbols/MUN-1SP/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T20:10:02", "published_display": "25 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tranche Update on Surgery Partners, Inc.'s Equity Buyback Plan announced on March 2, 2026.", "summary": "Surgery Partners, Inc. reported an update on its equity buyback plan, originally announced on March 2, 2026. Between February 26, 2026, and March 31, 2026, the company did not repurchase any shares or allocate any funds towards the buyback plan. This indicates no activity in the ", "url": "https://www.marketscreener.com/news/tranche-update-on-surgery-partners-inc-s-equity-buyback-plan-announced-on-march-2-2026-ce7f5cd3dd80f522", "source_name": "www.marketscreener.com", "published_at": "2026-06-22T12:40:43", "published_display": "22 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Fast-paced Mover Surgery Partners (SGRY) Is a Great Choice for Value Investors", "summary": "Surgery Partners (SGRY) is identified as an attractive investment for value investors due to its fast-paced momentum and reasonable valuation. The stock has shown significant price increases over recent weeks and boasts a high beta, indicating strong market movement. Additionally", "url": "https://finance.yahoo.com/markets/stocks/articles/why-fast-paced-mover-surgery-125502095.html", "source_name": "Market source", "published_at": "2026-06-22T06:55:00", "published_display": "22 Jun 2026 06:55", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Surgery Partners (NASDAQ:SGRY) In The Context Of Other Outpatient & Specialty Care Stocks", "summary": "This article analyzes Q1 earnings for outpatient and specialty care stocks, highlighting Surgery Partners (NASDAQ:SGRY) performance. It also compares SGRY with top performer agilon health (NYSE:AGL) and weaker performer U.S. Physical Therapy (NYSE:USPH), along with Select Medical", "url": "https://www.theglobeandmail.com/investing/markets/stocks/SGRY-Q/pressreleases/2553171/unpacking-q1-earnings-surgery-partners-nasdaqsgry-in-the-context-of-other-outpatient-specialty-care-stocks/", "source_name": "The Globe and Mail", "published_at": "2026-06-20T01:40:43", "published_display": "20 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners Stock - weekly sector check after quiet news flow", "summary": "Surgery Partners (SGRY) stock has shown modest gains recently with quiet news flow. This article provides a weekly sector check, comparing SGRY's performance against healthcare peers and the broader market, and offers an overview of the company's operations and key financial fact", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/surgery-partners-stock-weekly-sector-check-after-quiet-news-flow/69584674", "source_name": "AD HOC NEWS", "published_at": "2026-06-19T17:39:41", "published_display": "19 Jun 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGRY - Outpatient Shifts And CMS Changes Will Expand Surgical Potential", "summary": "Surgery Partners (SGRY) is positioned for growth due to outpatient surgical shifts and favorable CMS changes, yet faces near-term challenges. Recent analyst re-evaluations, following Q4 results and updated 2026 guidance, show a mixed outlook regarding margins, payer mix, and M&A ", "url": "https://simplywall.st/narratives/3ichyd7r-outpatient-shifts-and-cms-changes-will-expand-surgical-potential-v7so?bpId=4630650&link_type=cta_narrative_prompt_after_quote", "source_name": "Simply Wall Street", "published_at": "2026-06-19T15:39:40", "published_display": "19 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-analysts-see-26-135503736.html", "source_name": "Zacks", "published_at": "2026-06-18T13:55:03+00:00", "published_display": "18 Jun 2026 13:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners vs. Viemed Healthcare: Which Outpatient Care Stock Is a Better Buy in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNdHN4Z2Q0Njh1c1pxNzVLRnczcHV2cHNLZWI1QnVNbTBTVU5XNHhjcXdEeG9UNnBObGRrcGNFbjdqdG16SE5qY016a3hKbElqdVZKNHREMzZ2TkJLcGFtcjBjRndKTmhTV0p0OXVaZks2cFBubjlDOGtVVXpyS0pkY0RsUUV2SWNZWFUzNzRQOGRkRm5KTlFRRk05aGIwM3VIVXdUb3FpcGVJTWlDamJlLXl3WnFpY09tVi13ZU9OOU04bE1QZ2pCbkM0c29HZkRyenpjRmhXSXdMZw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Revealing Analyst Questions From Surgery Partners\u2019s Q1 Earnings Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPQTNEUjJteWFoUzl2WEJPbE1RdnBUTno5QndjNGdSdEFGTFd0OXNFYmNFTUtXNy0xRmota3BGeVhmbFpRTG9BdTZwNWRMeDJETWxqT0lycUE1QjM5azVjOVQ1aC1xdVRmbEZvakxCMV93eUlpanFtSGJJeWxKMTJpWlR5VVhTQVpETmhNYVpJNXQ0bS1sRk9IejlMdWhHVmZuRDdHWE9Wa20yVEU4TFoxMHdvVW0yU0l5R29Nak5mQ0JwNmlyRmc3TEVRTXVmdw?oc=5", "source_name": "StockStory", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) Losses Of US$77.9 Million Keep Profitability Narrative Under Pressure", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Surgery Partners Q1 2026 earnings beat forecasts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxObEFQbkJNTFNCdWVkcmZDZTZSNmZGcTZEMlJKUTdBTW9tMFM3TjJhaGN3cDRSNmMxcmJ3T3Utb0Q5MUlJTkMtNFZVNUhZbG9YRlYxczd4clZMXzZlbG9oeVFpa0M5WlBxYzFMZmJLY3c5RVBFSklrWnpodTcwYklDcnNIcS1aSUxzS2VRQXV6bkNaMV9lVl9NRnhaaEFKSEdaNUlDZWdwRldmUVpJdVpxa3FoNzJEcDNoVkZHY2dRRUZtSWJZeHZQag?oc=5", "source_name": "Investing.com", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners\u2019s (NASDAQ:SGRY) Q1 CY2026 Sales Beat Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQZ1VBajBVMzJUZFgtUmpkaFJMU1dlWGlTYW80ZGxORGRRX0hRNzlBeDFELWllY2pJUjBLSm9IUWpfSFpPVkJwaTdYT1hDQXF6ODQ4cmxqS0ZQRDhacFhsOUhiRTJpbFVQcUdMbUw3cTJ3WDJvUTMtZVQtUzd0d0ZVU3Z4SHp1Zy1KcEMxV1FaQU9sWFNUOW1ETmh2ZmJmcWVFaEpQQjY5cDU4R09zRjhyMENNa1JPR2ZMc0E?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOdzRxakh6ZW1DeTZ2aEY3SjZYLTgzMmpxY1AtTW9mOFM2c1BjZkNhNFNRbzlRYW9GTERPWmpPQ1o1NEZ6YlB4aFFkb1UtWUVpRndHT1lRVzdzbjNHZXU1UmpjSGtmczh0MEtOZWI5Q1dNM2dPMk04ZDR3YTZtQW1FQmZjYloyanktNnY5VmlUTlBtQXFkYkxwYnNIU1QxV1NOYU9z?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners Inc. (SGRY): Billionaire Brian Higgins Likes This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQWHgwM1VFTlBNUHEyZ3Z4ZW9aZnJiVHFhYjdZWllGVU95OVBtbzBtbENBTHNxUGJ5ODNrODBDZzU0NFEyTDRCbko2bUd5OUNrRHNYVnNzNkR4VkFrc2xWQnN5YlM3UzB3d3M2YlVubEgxc1FoU05OZWlCZGZLTFZhNXJlT2E0eVZwODJSbUx4cGk1eXlsSnJoaGVJU0ZGODBxNjVBNA?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners posts Q1 results May 5, webcast at 8:30 ET", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOT1d3Z2VHZWQ5a0dkNm56SXBVTlNhZzZSTFNzLTZvMlU4VTJwb0xFS2I5czZTZldGRWFlQWpyV3AxeFJuWnRxR2xRbTRFcTNpZ3lhcTc2U045MGNqM2V0ZHZNaDctZUJwR3B2ZFVHNWQ0YVBlbXpMNFF6Y1JJZzBZX0dTSzE3WVVHOHJ1WThwRUk0bEVWbG1vaG1kSzZSTk9BNnBYRUlhWmRSZk01OUZvMzBzLW9rYk95SXhpaHNR?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evans, Surgery Partners CEO, sells $254k in SGRY stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNcENTWTBwVS13YXByN2g5VU9idnR6N0RjYXlyQVJ6SzVmQktaRWN6Q2NnNVlRXzN5SFZBeTRLakpoT2FvbGJzaFZJc3lnZ0E3SnNteXE1NTBHNjgyc3g1cWlTNEdwSWlLMVNJZDFQYUt1OFA4M0lJRExhNXpMMlBjN00ySk9mUndyRTBab1lrTklQT0hVV2NON1N1WURueThQZUxHMmFLazFVTW9xOHpRUmZVQTRoUEU?oc=5", "source_name": "Investing.com", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hear Surgery Partners\u2019 Barclays healthcare presentation live online", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOODlMcU1OZUh1bFdGUEVQSHhtclRBNVZmWHB1OXNJSVlIZ3h3VDJ2S1V4YWpsV19jazhpcHZxa2pWU3ZFQzFKV29QYzJ4bGJiM0ZpZ1ZBSUM4anBLR05WTm0tWi1vT1JsQVF6bFNvR2pJQjJoSk5QcnQtNGNmWGNXNW1tZ0t4bjF3UXhBME9OQ0t3NlUtRlZxMmtnQlBLaENkeDhhMXh4c1NJN28?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Outpatient & Specialty Care Stocks Q4 Highlights: Surgery Partners (NASDAQ:SGRY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNanVnVjNMRHM3LUE1WXd1Unh3WUpPQnpsUTRkeXA3cFU1WV9xX3BvMV84aE9aWnFhYnJndlN4RjN0dlplNV9Md3VobHJyZS0xXzBxODc4UGhBVndndmRfbEdFbWpLVkpkVng3NVZsY2VvaFczdDV5OFVscmdpcnRtUDRqeXRSWWVXd2FNZXRUa2ZmMTlGcVJELWhSd1VYXy1LVHJLSU1QVjRpZw?oc=5", "source_name": "Finviz", "published_at": "2026-03-08T08:00:00+00:00", "published_display": "08 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners Inc. (SGRY) Stock Falls on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOWnk4WUdjM1pFaTF1b21VMHMzZUwtUzhFWVYwNmhtNXUwYUhTU0REU00wQnNVUjN4TlBveERWMDhXc3ZPM1VxbTBmWDBlX1F6a2E3RzJSWjdiVmdYSkJ0N1dOYUh0ZkJVOUFwQ2d2eVctN2kxdnFXcXBrZ2FNY0JLNTdFMndoT084NFlHdXRvT3hpQktSTkp1LU56SW9zQQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners schedules March 3 call to explain Q4 2025 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOdEN6MXVtY0dUc1BKR08zcm9sU25NWVF1bkUtUjRLSUN2b3huWjdfc0gxYWdLelRNV2gtcnhGaGt2UU1LN2lTRm5YWG50XzBaOGVIVXE0ZU5UX3BObEpabmxfWHYtUU81SGl2RnRZdnRGeG5qbk9IbTRwR01sR2VFcnRJaUtDanB6eF84NlR2R082Ym01YmhJajAyeFE3SjFxbTVyeHBfaDlPTnljbFI4eGtGX2ZINGJkaGVSeFNuVQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNUktKT2wzSEZMelh1cjhlWmJyZFNRSWtBZXhsMzVkc2ZKVW0zR2J0T0FpWC1YOXZ1SjRucnJNLTQ4ZGRVN2E2WVdNenI5U3VWeUZxekw2V2Z0TXZZU1RDcjJjSTV5WjVLSHpXeU92cU1BRVpkWno4Q1Y5U0NyWkdneFN5ZWN4ZE5lcmJXaG5yaUZKZ1VnWmNlYXhPTm9UMXZMYW8tOHZFeEpHYlhVc1lhbnd1WUVrWG9pY3BndEtoUF8?oc=5", "source_name": "The Motley Fool", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Surgery Partners (SGRY) Is Down 26.1% After Lower Q3 Results and Reduced 2025 Revenue Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQN25zTW1GUkN6eTZEMXB4Tk5wN1BtRUxTSzhzMWRsdkl4aV96eHZNX0ZmVU04VHBtd0pYQzBlUzN4ZUdZRnpBTm1mUE1XMGdJSEp3aEhXeHdrUlJMcTdWYWpyNU1wbHd1X2UzYUhWa3BpcHBtcks0ckh5RW5CWjlyNkZ3?oc=5", "source_name": "Market source", "published_at": "2025-11-11T08:00:00+00:00", "published_display": "11 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Surgery Partners (SGRY) Stock Is Trading Lower Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOT1VZRnVUZjZTZ21RM1YxdmxIN2xpZ2tfVDlHSVRUMjByUWNvSXdNckw2WjBCQ0hSZnZEWUZ1Y1ZWdUtzWVN5TEFGcDJERWpkQXhtUmpDaUhHNzVMY0VTek1pMnlYcnlkTlV5WVFhOUNnVFFGZUhiY0d3aGxpamNpLTFfRQ?oc=5", "source_name": "Market source", "published_at": "2025-11-10T08:00:00+00:00", "published_display": "10 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 93, "total_relevant": 48, "sentiment_summary": {"positive": 11, "negative": 6, "neutral": 31, "score": 52, "total": 48, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 13.55, "count": 24}, {"event": "earnings", "label": "Earnings", "weight": 8.8, "count": 16}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 16.4, "latest_week": "2026-07-10", "one_week_move": -4.8, "four_week_move": 7.1, "twelve_week_move": 17.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.426189, "market_dynamics_buy_signal": false, "relative_strength": -18.598739, "fair_value_gap": -31.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.9018, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.8% over one week, +7.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 14}, {"label": "Market source", "count": 7}, {"label": "Stock Titan", "count": 4}, {"label": "Investing.com", "count": 4}, {"label": "Simply Wall Street", "count": 3}, {"label": "Finviz", "count": 2}, {"label": "The Motley Fool", "count": 2}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 48}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Earnings", "count": 16}, {"label": "Analyst action", "count": 3}, {"label": "Regulatory and legal", "count": 2}, {"label": "Capital return", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "48", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.8% over one week, +7.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Form 4 Surgery Partners Inc For: 14 July By Investing.com"}], "updated_at": "2026-07-17T21:22:32.231421+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}